Company Description
A terror from the past has provided hope in the present. Celgene's flagship products Thalomid and Revlimid are versions of the infamous...
Key Celgene Financials
| Company Type | Public - NASDAQ (GS): CELG Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1,405.8 |
| 2007 Employees | 1,685 |
More Celgene Financials (11 pages)
Latest Celgene Jobs jobs by Indeed
Rankings
- S&P 500
- #370 in FT Global 500
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Celgene's competition across multiple industries
Top Celgene Competitors
Sponsored Links
The Business Directory
Celgene Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Sol J. Barer | Network | E-mail |
| President, COO, and Director | Robert J. (Bob) Hugin | Network | E-mail |
| SVP and CFO | David W. Gryska | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Celgene News
- BioWorld Today September 5, 2008 [BioWorld Today] (05 Sep 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (04 Sep 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (04 Sep 2008 22:00:00 EDT)
Sponsored Opportunity
